Ascendis Pharma Oncology Division A/S

Clinical research in locally advanced and metastatic solid tumor malignancies, including a broad range of cancer types across multiple active sites in Europe and beyond.

• Advanced or metastatic solid tumors
• Platinum-resistant ovarian cancer
• Second-line or later cervical cancer
• Second-line or later HER2-positive breast cancer

The sponsor’s oncology portfolio includes disease settings where treatment resistance and later-line management are central clinical concerns.